Cancer Exosomes Express CD39 and CD73, Which Suppress T Cells through Adenosine Production
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Extracellular adenosine is elevated in cancer tissue, and it negatively regulates local immune responses. Adenosine production from extracellular ATP has attracted attention as a mechanism of regulatory T cell-mediated immune regulation. In this study, we examined whether small vesicles secreted by cancer cells, called exosomes, contribute to extracellular adenosine production and hence modulate immune effector cells indirectly. We found exosomes from diverse cancer cell types exhibit potent ATP- and 5'AMP-phosphohydrolytic activity, partly attributed to exosomally expressed CD39 and CD73, respectively. Comparable levels of activity were seen with exosomes from pleural effusions of mesothelioma patients. In such fluids, exosomes accounted for 20% of the total ATP-hydrolytic activity. Exosomes can perform both hydrolytic steps sequentially to form adenosine from ATP. This exosome-generated adenosine can trigger a cAMP response in adenosine A(2A) receptor-positive but not A(2A) receptor-negative cells. Similarly, significantly elevated cAMP was also triggered in Jurkat cells by adding exosomes with ATP but not by adding exosomes or ATP alone. A proportion of healthy donor T cells constitutively express CD39 and/or CD73. Activation of T cells by CD3/CD28 cross-linking could be inhibited by exogenously added 5'AMP in a CD73-dependent manner. However, 5'AMP converted to adenosine by exosomes inhibits T cell activation independently of T cell CD73 expression. This T cell inhibition was mediated through the adenosine A(2A) receptor. In summary, the data highlight exosome enzymic activity in the production of extracellular adenosine, and this may play a contributory role in negative modulation of T cells in the tumor environment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Clayton et al. reported the expression of CD39, CD73, and eADO in MPM-derived exosome from pleural effusion, contributing to the inhibition of T cell functions [133].”
From Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma (2023) · cites this paper as [133]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids
Théry, C., Amigorena, S., Raposo, G., & Clayton, A. (2006) · Current Protocols in Cell Biology · doi:10.1002/0471143030.cb0322s30 · Cited by 5,766 · cited 1×
“To quantify the density of exosomes, we used a protocol similar to that previously described, based on ultracentrifugation on a linear sucrose gradient (36).”
MethodSelf-citationMembrane vesicles as conveyors of immune responses
Théry, C., Ostrowski, M., & Segura, E. (2009) · Nature Reviews Immunology · doi:10.1038/nri2567 · Cited by 3,882 · cited 1×
“immune-activating functions, there are also accumulating data pointing to varied suppressive effects (40).”
BackgroundB lymphocytes secrete antigen-presenting vesicles.
Raposo, G., Nijman, H. W., Stoorvogel, W., Liejendekker, R., Harding, C. V., Melief, C. J., & Geuze, H. J. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.1161 · Cited by 3,546 · cited 1×
“The density (g/ml) of each fraction was calculated from the published table in the Beckman Ultracentrifugation catalogue as described (37).”
MethodDeaglio, S., Dwyer, K. M., Gao, W., Friedman, D., Usheva, A., Erat, A., Chen, J.-F., Enjyoji, K., Linden, J., Oukka, M., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062512 · Cited by 2,470 · cited 5×
“These are double-positive for CD39 and CD73 in mice (12) and according to one report also in human (45).”
BackgroundInfluentialOhta, A., & Sitkovsky, M. (2001) · Nature · doi:10.1038/414916a · Cited by 1,334
Borsellino, G., Kleinewietfeld, M., Di Mitri, D., Sternjak, A., Diamantini, A., Giometto, R., Höpner, S., Centonze, D., Bernardi, G., Dell'Acqua, M. L., et al. (2007) · Blood · doi:10.1182/blood-2006-12-064527 · Cited by 1,286 · cited 3×
“Natural regulatory T cells of mice express both CD39 and CD73, whose coordinated enzymatic actions produce adenosine as a mechanism for immune suppression that is independent of IL-10 and TGF-b (12, 13).”
BackgroundAdenosine receptors: therapeutic aspects for inflammatory and immune diseases
Haskó, G., Linden, J., Cronstein, B., & Pacher, P. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2638 · Cited by 1,217 · cited 1×
“mechanisms involved in adenosine formation and subsequent signaling are therefore of considerable therapeutic interest (9).”
BackgroundA2A adenosine receptor protects tumors from antitumor T cells
Ohta, A., Gorelik, E., Prasad, S. J., Ronchese, F., Lukashev, D., Wong, M. K. K., Huang, X., Caldwell, S., Liu, K., Smith, P., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605251103 · Cited by 1,065 · cited 1×
“Adenosine also represses immune responses in the tumor microenvironment, assisting tumor immune evasion (7, 8).”
BackgroundMalignant effusions and immunogenic tumour-derived exosomes
Andre, F., Schartz, N. E., Movassagh, M., Flament, C., Pautier, P., Morice, P., Pomel, C., Lhomme, C., Escudier, B., Le Chevalier, T., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09552-1 · Cited by 953 · cited 7×
“The cushion was collected and exosomes washed in PBS (32, 34, 35).”
MethodInfluentialExoCarta: A compendium of exosomal proteins and RNA
Mathivanan, S., & Simpson, R. J. (2009) · PROTEOMICS · doi:10.1002/pmic.200900351 · Cited by 873
Cited by
Items 501–564 of 564
Exosomes - the future of vaccination?
Gehrmann, U. (2011) · Figshare
Exosomal regulation of TGF-β signalling
Liu, L. (2015) · Minerva Access (University of Melbourne) · Cited by 1
Gautheron, A. (2015) · theses.fr (ABES) · doi:10.70675/1b60a990z1015z4f47z8c2fz84a6b408d4f1
Extracellular Vesicles and RNA interference in tumors
Lunavat, T. R. (2016) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Onishi, H., Morisaki, T., & Katano, M. (2016) · Springer eBooks · doi:10.1007/978-4-431-55031-0_21
Tumor Stroma, Desmoplasia, and Stromagenesis
Zimmermann, A. (2016) · Springer eBooks · doi:10.1007/978-3-319-26587-2_185-1
Outram, S. P., & Leibovich, S. J. (2013) · CRC Press eBooks · doi:10.1201/b14842-5
Mesenchymal stromal cell extracellular vesicles/exosomes
Yeo, R. W. Y., Lai, R. C., & Lim, S. K. (2016) · Wiley eBooks · doi:10.1002/9781118907474.ch20
Funktion von extrazellulären Vesikeln und Bedeutung für die labormedizinische Diagnostik
Reiners, K. S., Daßler‐Plenker, J., Coch, C., & Hartmann, G. (2017) · Journal of Laboratory Medicine · doi:10.1515/labmed-2017-0078 · Cited by 2
“Zudem sind für Tumor-EV vielfache T-Zell-inhibierende Eigenschaften nachgewiesen worden: eine verstärkte Expression inhibitorischer Gene in CD4-positiven T-Zellen; die Expression von Ektonukleotidasen CD73 und CD39, die über erhöhte extrazelluläre Adenosinproduktion T-Zellen supprimieren; die Hemmung des T-Zell-Rezept…”
BackgroundThe Role of Myosin- and Rab-Interacting Protein (MyRIP) in Exocytosis and the Response to DNA Damage
Tickner, J. A. (2017) · Queensland University of Technology · doi:10.5204/thesis.eprints.112763
Avaliação das ectonucleotidases como biomarcadores na progressão do câncer de próstata
Gardani, C. F. F. (2018) · Americanae (AECID Library)
Scholl, J. N. (2019) · Americanae (AECID Library)
mRNA-based therapeutics to induce immunity against cancer and infectious diseases
Hoecke, L. V. (2020) · Ghent University Academic Bibliography (Ghent University)
Extracellular Vesicles in Colorectal Cancer Progression, Metastasis, Diagnosis, and Therapy
Merlin, M., Prabhakar, P. K., Shukla, D., Tiwari, A. K., & Saxena, S. (2021) · Springer eBooks · doi:10.1007/978-3-030-64668-4_17
Conroy, C. M. (2021) · Arrow@dit (Dublin Institute of Technology) · doi:10.13025/16183
Tumor Stroma, Desmoplasia, and Stromagenesis
Zimmermann, A. (2016) · Springer eBooks · doi:10.1007/978-3-319-26956-6_185 · Cited by 1
Extracellular vesicle therapeutics: from mechanism to application in cardiac repair
Roefs, M. T. H. F. (2022) · Utrecht University Repository (Utrecht University) · doi:10.33540/1547
Which technology performs better? From sample volume to extraction and molecular profiling
Capoluongo, E., Pisapia, P., Malapelle, U., & Troncone, G. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-822703-9.00004-1
Distal Onco-Sphere: Molecular Mechanisms in Metastasis
Saw, P. E., & Song, E. (2023) · Springer eBooks · doi:10.1007/978-981-99-1183-7_14
Avaliação do eixo ATP-adenosina na infecção por SARS-CoV-2
Pietrobon, A. J. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2023.tde-12092023-151647
Exosomes derived from dairy cows for diagnostics
Abeysinghe, P. (2023) · Queensland University of Technology · doi:10.5204/thesis.eprints.244459
Extracellular Vesicles in Inflammation
Hämälistö, S., & Al-Ghadir, L. (2024) · Biology of extracellular matrix · doi:10.1007/978-3-031-68811-9_5
Chimote, A. A., Alshwimi, A. O., Venkatraman, S., Bhati, J., Lehn, M. A., Chutipongtanate, S., Das, S., Kasper, S., Rai, S. N., Langevin, S. M., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.25.666838
Exosome-mediated tumor immunology and the application of synthetic biology in cancer treatment
Liu, C., Sun, B., Dong, W., Li, S., & Yumiao, Z. (2025) · Scientia Sinica Vitae · doi:10.1360/ssv-2025-0237
Role of Extracellular Vesicles in Cancer Pathogenesis
Elewaily, M. I. (2025) · Springer eBooks · doi:10.1007/978-3-032-00759-9_42
Adenosine in the Immune System
Haskó, G., Koscsó, B., & Csóka, B. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3903-5_12 · Cited by 1
Guetter, S. (2025) · University of Regensburg Publication Server (University of Regensburg) · doi:10.5283/epub.53739
Shi, M., Ye, L., Zhao, L., He, L., Chen, J., Zhang, J., Su, Y., Dong, H., Liu, J., Liang, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26721567
Shi, M., Ye, L., Zhao, L., He, L., Chen, J., Zhang, J., Su, Y., Dong, H., Liu, J., Liang, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26721564
Mallardo, D., Fordellone, M., White, A. M., Ottaviano, M., Sparano, F., Bailey, M. D., Facchini, A. B., Ong, S., Maiolino, P., Caracò, C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26616109
Shi, M., Ye, L., Zhao, L., He, L., Chen, J., Zhang, J., Su, Y., Dong, H., Liu, J., Liang, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25844432
Shi, M., Ye, L., Zhao, L., He, L., Chen, J., Zhang, J., Su, Y., Dong, H., Liu, J., Liang, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25844532
Gonçalves, F. D. C. (2017) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Adenosine metabolism in cancer: unveiling new therapeutic opportunities
Losenkova Mingeaud, K. (2025) · UTUPub (University of Turku)
Haas, S. R., Wollenberg, B., & München, T. U. (2024)
Tortajada, M., & Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, D. F. I. D. (2018) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
CD73 in triple-negative breast cancer
Petruk, N. (2023) · UTUPub (University of Turku)
Molecular mechanism characterization of innovative small molecules in cancer immunotherapy
Dziedzic, K. (n.d.) · Jagiellonian University Repository (Jagiellonian University)
Exosomes as messengers: intercellular communication
Donato, L., Mordà, D., Abate, G., & Alibrandi, S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-36390-0.00010-5
Autophagy : A New Modulator of Immunogenic Cell Death for Cancer Therapy
Sukkurwala, A. Q. (2013) · theses.fr (ABES) · doi:10.70675/4f8d1af3zb683z4af9z8623z961dff8c78f4
歯肉幹細胞由来エクソソームは、M2分化を誘導し、歯槽骨吸収を抑制した
NAKAO, Y. (2021) · Institutional Repositories DataBase (IRDB)
Lhuillier, C. (2016) · theses.fr (ABES) · doi:10.70675/d067b27ez2081z49d2z94f5z87680adf071c · Cited by 1
Shekarian, T. (2017) · theses.fr (ABES) · doi:10.70675/31550ddbz6cf7z4e25za126z01b3fb8737f1
Effect of nasopharyngeal carcinoma derived exosomes on the induction of tolerogenic dendritic cells
Renaud, S. (2018) · theses.fr (ABES) · doi:10.70675/41db8e5ez4572z4453zb3efz2631b3820222
Dumontet, E. (2020) · theses.fr (ABES) · doi:10.70675/12155076z603ez4c55zbedfz05c58338e7ad
Etude in vivo de la chimiorésistance dans les leucémies aigues myéloïdes humaines
Aroua, N. (2018) · theses.fr (ABES) · doi:10.70675/87716ea3z1f4dz4a62zb041z59f2afc4c3e9
Le rôle de deux alarmines extracellulaires, HMGB1 et l’ATP, dans le cadre du cancer colorectal
Dillard, C. (2021) · theses.fr (ABES) · doi:10.70675/51029938z640az4398za0f8z6a69fb660b30
Sato, A., & Ito, E. (2026) · World Journal of Methodology · doi:10.5662/wjm.120686
Paktinat, S., Gravett, M. G., Hughes, S. M., Spray, A. L. P., Gornalusse, G. G., Hladik, F., & Vojtech, L. N. (2026) · Human Reproduction Open · doi:10.1093/hropen/hoag064
“…molecules, such as HLA-G, which are implicated in tolerance to the semi-allogeneic fetus (Xu et al. , 2020; Aisagbonhi and Morris, 2022), and (ii) the ectonucleotidases, CD39 and CD73, which contribute to immune suppression through the generation of extracellular adenosine (Clayton et al. , 2011).”
Caracterización del perfil adenosinérgico de células dendríticas convencionales del tipo I
Varas, R. J. J. (2026) · Universidad de Chile
Beyond a Surface Marker: The Multifaceted Role of CD38 in Metabolic Disruption and Tumor Progression
Coşkun, Ö. (2026) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-026-02133-w
Samemaleki, S., Orooji, N., Kazemi, T., & Solgi, G. (2026) · PubMed Central · doi:10.22034/ibj.30.4.234
“This process suppresses T-cell functions in the extracellular matrix [27,28] .”
Zhang, W., Chen, N., Gong, L., Dong, Y., Shen, H., Liu, X., Sun, J., Liu, L., Jin, Z., Wang, L., et al. (2026) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2026.5989
Wang, J., Xiang, Z., Zhu, H., Zhu, H., & Wang, J. (2026) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2026.189725
BindingDB (2013) · UC San Diego · doi:10.7270/q2dr2wnz
Metadata
- Authors
- Clayton, A., Al-Taei, S., Webber, J., Mason, M. D., & Tabi, Z.
- Affiliations
- Velindre Cancer Centre (GB)
- Department of Pharmacology, Radiology and Oncology, School of Medicine, Cardiff University, Velindre Cancer Centre , Whitchurch, Cardiff CF14 2TL ,
- Corresponding author
- Clayton, Aled
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-07
- Volume
- 187
- Issue
- 2
- Pages
- 676-683
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2153092839
- Cited by
- 540
- References
- 49
- Citations by year
- 2026: 18 · 2025: 30 · 2024: 31 · 2023: 38 · 2022: 53 · 2021: 50 · 2020: 61 · 2019: 37 · 2018: 36 · 2017: 29 · 2016: 30 · 2015: 24 · 2014: 33 · 2013: 26 · 2012: 40
- FWCI
- 23.02
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Keywords
- tumor-derived exosomes, CD39, CD73, extracellular adenosine, ATP hydrolysis, 5'-AMP, adenosine A2A receptor, cAMP signaling, T cell activation inhibition, tumor immunosuppression, mesothelioma, extracellular vesicles
- MeSH terms
- Adenosine, Adenosine Monophosphate, Adenosine Triphosphate, Apyrase, Humans, Hydrolysis, Mesothelioma, Phosphorylation, Pleural Neoplasms, Down-Regulation, Antigens, CD, 5'-Nucleotidase, Caco-2 Cells, Jurkat Cells, Cell Line, Tumor, T-Lymphocytes, Regulatory, Exosomes, GPI-Linked Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.